Canadian Society of Transplantation

October 14, 2024 to October 18, 2024

Montreal, QC

The goal of the Canadian Society of Transplantation Annual Meeting is to connect members of the scientific community dedicated to the development of novel therapeutics with those involved in every aspect of solid organ transplantation, including clinicians, researchers, pathologists, immunologists, basic scientists, allied health care colleagues, policy makers and others. Be sure to join us at our booth to learn about our organ preservation systems.

Website: www.cst-transplant.ca/

Tagged In:

The Latest

Check out the most recent posts

Overcoming the longest cold ischemia time seen in Korea using HMP in deceased donor kidney transplantation

Clinical Evidence, News

Kim et al. reported on a deceased donor kidney transplant case that had the longest reported cold ischemic time (CIT) in Korea which was facilitated by using hypothermic machine perfusion (HMP). A 54 year old male marginal deceased donor (Korean Kidney Donor Profile...

Local12—Machine perfusion leading to more organ viability for liver transplants

News

Organ Recovery Systems (ORS) is honored to announce that UC Health, a Continued Access site in PILOT clinical trial has set a record in 2023 for most transplants in the US! We are thankful for our ongoing collaboration with UC Health and their success using LifePort...

Portable hypothermic oxygenated machine perfusion for organ preservation in liver transplantation (PILOT™): A randomized, open-label, clinical trial*

Clinical Evidence, News

Panayotova et al. published a multicenter, randomized, noninferiority trial which sought to compare liver preservation using the LifePort Liver Transporter to the standard of care, static cold storage. The study included 142 liver transplant procedures from 9 US...

Brief Bubble and Intermittent Surface Oxygenation Is a Simple and Effective Alternative for Membrane Oxygenation During Hypothermic Machine Perfusion in Kidneys

Clinical Evidence

A study by Darius et al. sought to evaluate the use of direct bubble and intermittent surface oxygenation during continuous HMP as an alternative to using a membrane oxygenator. They evaluated the renal flow, resistance and concentration of pO2 in the perfusate as...